Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Smolen

Showing results (881-890 of 1,467) with videos related to

Pageof 147
Sort By:
Annals of the Rheumatic Diseases|September 22, 2018
Can disease activity in patients with psoriatic arthritis be adequately assessed by a modified Disease Activity index for PSoriatic Arthritis (DAPSA) based on 28 joints?Brigitte Michelsen, Joseph Sexton, Josef S Smolen, et al.
Clinical and Experimental Rheumatology|March 14, 2018
Prevalence and validity of ACR/EULAR remission in four European early rheumatoid arthritis cohortsKarin Britsemmer, Dirkjan van Schaardenburg, Maarten Boers, et al.
Annals of the Rheumatic Diseases|March 11, 2016
The changing landscape of biosimilars in rheumatologyThomas Dörner, Vibeke Strand, Paul Cornes, et al.
Materials Today. Bio|February 8, 2021
Enzyme functionalized microgels enable precise regulation of dissolved oxygen and anaerobe cultureA S Jeevarathinam, F Guo, T Williams, et al.
The New England Journal of Medicine|August 24, 2022
Olokizumab versus Placebo or Adalimumab in Rheumatoid ArthritisJosef S Smolen, Eugen Feist, Saeed Fatenejad, et al.
Frontiers in Immunology|May 10, 2018
Determination of Autoantibody Isotypes Increases the Sensitivity of Serodiagnostics in Rheumatoid ArthritisDaniela Sieghart, Alexander Platzer, Paul Studenic, et al.
Seminars in Arthritis and Rheumatism|February 26, 2019
Risk profiling for a refractory course of rheumatoid arthritisManuel Bécède, Farideh Alasti, Irina Gessl, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2000
B and T cell responses to the spliceosomal heterogeneous nuclear ribonucleoproteins A2 and B1 in normal and lupus miceH Dumortier, F Monneaux, B Jahn-Schmid, et al.
Advances in Therapy|November 18, 2016
Impact of Treatment-Related Beliefs on Medication Adherence in Immune-Mediated Inflammatory Diseases: Results of the Global ALIGN StudyPierre Michetti, John Weinman, Ulrich Mrowietz, et al.
The Journal of Rheumatology. Supplement|June 2, 2004
Lefunomide in combination therapyJoachim R Kalden, Josef S Smolen, Paul Emery, et al.
Pageof 147

Showing results (881-890 of 1,467) with videos related to

Sort By:
Pageof 147
Annals of the Rheumatic Diseases|September 22, 2018
Can disease activity in patients with psoriatic arthritis be adequately assessed by a modified Disease Activity index for PSoriatic Arthritis (DAPSA) based on 28 joints?Brigitte Michelsen, Joseph Sexton, Josef S Smolen, et al.
Clinical and Experimental Rheumatology|March 14, 2018
Prevalence and validity of ACR/EULAR remission in four European early rheumatoid arthritis cohortsKarin Britsemmer, Dirkjan van Schaardenburg, Maarten Boers, et al.
Annals of the Rheumatic Diseases|March 11, 2016
The changing landscape of biosimilars in rheumatologyThomas Dörner, Vibeke Strand, Paul Cornes, et al.
Materials Today. Bio|February 8, 2021
Enzyme functionalized microgels enable precise regulation of dissolved oxygen and anaerobe cultureA S Jeevarathinam, F Guo, T Williams, et al.
The New England Journal of Medicine|August 24, 2022
Olokizumab versus Placebo or Adalimumab in Rheumatoid ArthritisJosef S Smolen, Eugen Feist, Saeed Fatenejad, et al.
Frontiers in Immunology|May 10, 2018
Determination of Autoantibody Isotypes Increases the Sensitivity of Serodiagnostics in Rheumatoid ArthritisDaniela Sieghart, Alexander Platzer, Paul Studenic, et al.
Seminars in Arthritis and Rheumatism|February 26, 2019
Risk profiling for a refractory course of rheumatoid arthritisManuel Bécède, Farideh Alasti, Irina Gessl, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2000
B and T cell responses to the spliceosomal heterogeneous nuclear ribonucleoproteins A2 and B1 in normal and lupus miceH Dumortier, F Monneaux, B Jahn-Schmid, et al.
Advances in Therapy|November 18, 2016
Impact of Treatment-Related Beliefs on Medication Adherence in Immune-Mediated Inflammatory Diseases: Results of the Global ALIGN StudyPierre Michetti, John Weinman, Ulrich Mrowietz, et al.
The Journal of Rheumatology. Supplement|June 2, 2004
Lefunomide in combination therapyJoachim R Kalden, Josef S Smolen, Paul Emery, et al.
Pageof 147